The Efficacy of Moclobemide in Treatment of Major Depression
The effectiveness and the tolerence of moclobemde -one of the reversible inhibitors of MAO-A were assessed in an open clinical trial on 19 inpatients with major depression according to DSM.III and with a score of 16 or more on Hamilton Rating Scale of Depression (HRSD). As a result, a statistically...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mesut Çetin
2021-03-01
|
| Серии: | Psychiatry and Clinical Psychopharmacology |
| Предметы: | |
| Online-ссылка: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/106 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|